ADAP1 limits neonatal cardiomyocyte hypertrophy by reducing integrin cell surface expression
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
ADAP1 limits neonatal cardiomyocyte hypertrophy by reducing integrin cell surface expression ; volume:8 ; number:1 ; day:11 ; month:9 ; year:2018 ; pages:1-13 ; date:12.2018
Scientific reports ; 8, Heft 1 (11.9.2018), 1-13, 12.2018
- Creator
-
Giguère, Hugo
- Contributor
-
Dumont, Audrey-Ann
Berthiaume, Jonathan
Oliveira, Vanessa
Laberge, Gino
Auger-Messier, Mannix
SpringerLink (Online service)
- DOI
-
10.1038/s41598-018-31784-w
- URN
-
urn:nbn:de:101:1-2018102323574833343437
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:26 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Giguère, Hugo
- Dumont, Audrey-Ann
- Berthiaume, Jonathan
- Oliveira, Vanessa
- Laberge, Gino
- Auger-Messier, Mannix
- SpringerLink (Online service)
Other Objects (12)
Succinate causes pathological cardiomyocyte hypertrophy through GPR91 activation
Inhibition of cardiomyocyte hypertrophy by heterocyclic thiourylenes in vitro
Circular RNA circZFPM2 regulates cardiomyocyte hypertrophy and survival
The functional role of m6A demethylase ALKBH5 in cardiomyocyte hypertrophy
MRI based non-invasive detection of cardiomyocyte hypertrophy and cell-volume changes
Testosterone activates glucose metabolism through AMPK and androgen signaling in cardiomyocyte hypertrophy
Sumoylation-independent activation of Calcineurin-NFAT-signaling via SUMO2 mediates cardiomyocyte hypertrophy
Sumoylation-independent activation of calcineurin-NFAT-signaling via SUMO2 causes cardiomyocyte hypertrophy
Changes in glutamic oxaloacetic transaminase 2 during rat physiological and pathological cardiomyocyte hypertrophy
Three-dimensional human pluripotent stem cell-derived cardiomyocyte models for investigating cardiac hypertrophy
Cardiomyocyte gene programs encoding morphological and functional signatures in cardiac hypertrophy and failure
Disruption of neonatal cardiomyocyte physiology following exposure to bisphenol-a
Succinate causes pathological cardiomyocyte hypertrophy through GPR91 activation
Inhibition of cardiomyocyte hypertrophy by heterocyclic thiourylenes in vitro
Circular RNA circZFPM2 regulates cardiomyocyte hypertrophy and survival
The functional role of m6A demethylase ALKBH5 in cardiomyocyte hypertrophy
MRI based non-invasive detection of cardiomyocyte hypertrophy and cell-volume changes
Testosterone activates glucose metabolism through AMPK and androgen signaling in cardiomyocyte hypertrophy
Sumoylation-independent activation of Calcineurin-NFAT-signaling via SUMO2 mediates cardiomyocyte hypertrophy
Sumoylation-independent activation of calcineurin-NFAT-signaling via SUMO2 causes cardiomyocyte hypertrophy
Changes in glutamic oxaloacetic transaminase 2 during rat physiological and pathological cardiomyocyte hypertrophy
Three-dimensional human pluripotent stem cell-derived cardiomyocyte models for investigating cardiac hypertrophy
Cardiomyocyte gene programs encoding morphological and functional signatures in cardiac hypertrophy and failure
Disruption of neonatal cardiomyocyte physiology following exposure to bisphenol-a
Succinate causes pathological cardiomyocyte hypertrophy through GPR91 activation
Inhibition of cardiomyocyte hypertrophy by heterocyclic thiourylenes in vitro
Circular RNA circZFPM2 regulates cardiomyocyte hypertrophy and survival
The functional role of m6A demethylase ALKBH5 in cardiomyocyte hypertrophy
MRI based non-invasive detection of cardiomyocyte hypertrophy and cell-volume changes
Testosterone activates glucose metabolism through AMPK and androgen signaling in cardiomyocyte hypertrophy
Sumoylation-independent activation of Calcineurin-NFAT-signaling via SUMO2 mediates cardiomyocyte hypertrophy
Sumoylation-independent activation of calcineurin-NFAT-signaling via SUMO2 causes cardiomyocyte hypertrophy
Changes in glutamic oxaloacetic transaminase 2 during rat physiological and pathological cardiomyocyte hypertrophy
Three-dimensional human pluripotent stem cell-derived cardiomyocyte models for investigating cardiac hypertrophy
Cardiomyocyte gene programs encoding morphological and functional signatures in cardiac hypertrophy and failure